Table 1. Characterization of XBP1s- and/or ATF6-Remodeled ER Proteostasis Environments.
Fold Change in Arraysa | Fold Change in Proteomicsb,c | |||||
---|---|---|---|---|---|---|
|
|
|||||
Protein | XBP1s | ATF6 | Both | XBP1s | ATF6 | Both |
ER Import | ||||||
Sec61A1 | 2.14 | NS | 1.95 | ND | ND | ND |
SRPR | 1.98 | NS | 1.84 | NS | NS | NS |
SRPRB | 1.99 | NS | 1.86 | 2.1 | NS | 1.7 |
SRP19 | 2.43 | NS | 2.11 | NS | NS | NS |
Hsp40/70/90 | ||||||
GRP78 (BiP) | NS | 2.24 | 2.30 | 1.6 (1.6) | 4.1 (4.5) | 3.9 (4.5) |
GRP94 | NS | NS | 1.26 | 1.3 (2.0) | 2.3 (4.7) | 2.2 (4.1) |
P58/IPK | 2.34 | 2.36 | 3.26 | NS | 1.5 | 2.2 |
ERDJ3 | 1.51 | 1.94 | 1.91 | ND (1.3) | ND (1.2) | ND (1.5) |
ERDJ4 | 4.89 | NS | 5.07 | ND | ND | ND |
ERDJ5 | 1.69 | NS | 1.92 | NS | NS | 1.8 |
HYOU1 | 3.37 | 4.64 | 6.32 | 1.7 (1.7) | 2.5 (2.0) | 3.1 (2.6) |
N-Glycosylation and Lectin-Assisted Folding | ||||||
STT3A | 1.80 | NS | 1.75 | NS | NS | NS |
DDOST | NS | NS | NS | 1.3 | NS | NS |
RPN1 | 1.64 | NS | 1.76 | 1.4 | NS | 1.2 |
CANX | 1.21 | NS | 1.29 | 1.2 | NS | NS |
CRT | 1.38 | 2.22 | 2.09 | 1.2 | 1.6 | 1.6 |
LMAN1 (ERGIC53) | 1.66 | NS | 1.52 | 1.7 | NS | 1.5 |
Disulfide Redox | ||||||
PDIA3 (ERP57) | 1.62 | 1.76 | 1.80 | 1.2 | 1.2 | 1.3 |
PDIA4 | 2.74 | 4.57 | 4.32 | 1.7 | 3.0 | 3.1 |
PDIA6 | 1.62 | NS | 1.98 | 1.3 | 1.4 | 1.4 |
ERO1L | NS | 1.28 | 1.38 | NS | NS | 1.2 |
ERO1LB | 2.78 | 2.13 | 3.44 | ND | ND | ND |
Quality Control and Degradation | ||||||
EDEM1 | NS | NS | 4.18 | ND (1.4) | ND (0.9) | ND (2.5) |
EDEM2 | 2.08 | NS | 2.13 | ND | ND | ND |
EDEM3 | 1.76 | NS | 1.82 | ND | ND | ND |
DERLIN2 | NS | NS | 2.76 | ND | ND | ND |
SYVN1 (HRD1) | 2.07 | NS | 2.67 | ND | ND | ND |
VCP (p97) | NS | NS | 1.77 | 1.3 | 1.3 | 1.3 |
HERPUD1 | 4.19 | 8.27 | 8.62 | ND | ND | ND |
XTP3B | 2.27 | NS | 2.32 | ND (1.6) | ND (1.0) | ND (1.9) |
OS9 | NS | 1.60 | 2.15 | ND (0.9) | ND (1.6) | ND (1.6) |
SEL1L | 1.76 | 4.36 | 4.32 | NS | NS | 2.0 |
Anterograde Trafficking/Golgi | ||||||
SEC23B | 1.77 | NS | 1.71 | 1.6 | NS | 1.5 |
SEC24D | 5.48 | NS | 5.60 | NS (3.7) | NS (0.9) | NS (3.1) |
SEC31A | 2.05 | NS | 2.60 | NS | NS | 2.0 |
GOLGB1 | 1.86 | NS | 1.81 | 1.6 | NS | 1.5 |
Miscellaneous | ||||||
DDIT3 (CHOP) | NS | NS | 2.67 | ND | ND | ND |
WIPI1 | 3.14 | 3.61 | 5.71 | ND | ND | ND |
MSTO1 | NS | NS | 4.63 | ND | ND | ND |
SULF1 | NS | 5.17 | ND | ND | ND | |
CRELD2 | 3.07 | 4.80 | 8.04 | ND | ND | ND |
NS, not significant; ND, not detected.
FDR <0.05.
FDR <0.1.
Quantity in parentheses is from immunoblotting (see also Figure S2).